Non-invasive in vitro method to detect transitional cell carcinoma of the bladder
CN1860121A
Substituted imidazopyrimidines for the prevention and treatment of cancer
EA008798B1
NEW BENZAMIDES AS PRARγ MODULATORS
WO2004004682A2
Stable oily suspension of microgranules
CN1832948A
1- alkyl-1-azoniabicyclo (2.2.2) octane carbamate derivatives and their use as muscarinic receptor antagonists
ES2180456A1
SUBSTITUTED ISOXAZOLS AND ITS USE AS ANTIBIOTICS.
IL153707D0
Carbamates derived from arylalkylamines
ES2153786A1
Liquid pharmaceutical composition for the oral administration of amarge and susceptible active hydrolysis principles.
ES2140354A1
IMIDAZO (1,2A) AZINAS SUBSTITUTED AS SELECTIVE INHIBITORS OF COX-2.
AU4708697A
Process for the preparation of eberconazol and intermediates thereof
ES2105971A1
Antibiotic / anti-inflammatory composition of otic application.
ES2105970A1
Oral pharmaceutical composition of ciprofloxacino, non-aqueous, stable and with improved organoleptic characteristics.
ES2092957A1
Intermediate preparation procedure for the synthesis of dichloro-substituted derivatives with antifungal activity.
ES2094687A1
Pharmaceutical combination against obesity or overweight.
ES2095183A1
Acususing gelificing compositions for the intranasal administration of pharmaces.
ES2074030A1
Carrier, self-heating and applicable compositions in therapeutics by via topica.
ES2063705A1
Intermediate for the synthesis of lansoprazole and its procedure for obtaining.
ES2065269A1
6- (4- (fenilbutoxi) hexilaminometil-4-hidroxi-a1, a3-bencenodimetanol. procedure for the obtaining of the same and new intermediates used in its preparation.
ES2053394A1
"3-bromine-4-oxo-1-ethyl piperidincarboxylate, procedure for obtaining the same and new intermediates used in its preparation"
ES2053395A1
"4-cinnamoiloxi-2-methyl-n- (2-piridil) -2h-1,2-benzotiazine-3-carboxamide 1,1-dioxide, procedure for the obtaining of the same and new intermediates used in its preparation.
